Skip to content

Clinical trials

Observational Bronchiectasis trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Bronchiectasis Phase: Observational Clear all

121 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20052
20061
20082
20092
20101
20116
20123
20132
20144
20157
20164
20175
20186
20199
20208
202110
20225
202311
20248
202520
20264

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Unknown status38
Recruiting36
Completed32
Not yet recruiting5
Active, not recruiting4
Terminated2
Withdrawn2
Suspended1
Enrolling by invitation1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Assiut University10
Shanghai Pulmonary Hospital, Shanghai, China8
Hacettepe University5
Union Hospital, Tongji Medical College, Huazhong University of Science and Technology4
First Affiliated Hospital of Ningbo University3
Imperial College London3
Papworth Hospital NHS Foundation Trust3
Ruijin Hospital3
The First Affiliated Hospital of Guangzhou Medical University3
Atlas University2

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Bronchiectasis121
Pulmonary Disease, Chronic Obstructive37
Asthma24
Cystic Fibrosis12
Lung Diseases, Interstitial9
Lung Diseases7
Disease6
Lung Neoplasms6
Bronchitis5
Ciliary Motility Disorders4

Trials

Showing 76 to 100 of 121. Each trial links to its page on Pharma Observatory.

21 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.